A Comparative clinical study to evaluate the effect of Jyotishmatyadi churna alongwith Satpushpa taila Matra basti in the management of Artavakshaya wsr to Oligo-Hypomenorhhea

The study is entitled as – “A comparative clinicalstudy to evaluate the effect Jyotishmatyadi churna

alongwith Satpushpataila Matra Basti in the management of Artavakshaya w.s.r.Oligo-Hypomenorrheaâ€.

 Objective of study – To compare the efficacy ofJyotishmatyadi churna and Jyotishmatyadi churna

alongwith Satpushpa taila Matra Basti in the management ofArtavakshaya w.s.r. Oligo-Hypomenorrhea.

 Type of study – Randomized comparative open clinicaltrial.

 Administration of trial therapy – Minimum 40 patienthaving cardinal symptoms of Artavakshaya will

registered into groups.

 Group A – Jyotishmatyadi churna ( 3 gm ) twice a daywith milk after meal ( after clearance of menses ).

 Group B – Jyotishmatyadi churna ( 3 gm ) twice a daywith milk after milk and Satpushpa taila Matra

Basti ( 60 ml ) once in a day for 9 days ( after clearanceof menses ).

 Duration of period – 3 consecutive cycles ( 2 cycleswith trial drug and one cycle drug free follow up ).

 Therapy period – 2 consecutive cycles after clearanceof menses.

Follow up during treatment – On the clearance of eachmenstrual cycle during the period of treatment.

 Criteria for selection of patient -

Diagnostic criteria –   Diagnosis will be based on the presence of anyone or more of the cardinal symptoms of Artavakshaya.

A.     Yathochitakala Adarshanam of Artava –Menstrual cycle > 35 days

B.     Alpartavam –

1.      Duration of bleeding < 2 days

2.      Decrease in quantity of Bleeding

**C.**Yoni Vedana

Inclusion criteria –

 1.    1  . Patients between age group of 18 – 40 years.

2.     2 . Patients fulfilling the cardinal symptoms ofArtavakshaya.

3.     3 . Patients willing to participate in the studywith proper written consent.

 Exclusion criteria –

 1.      Patient having systemic disease (HTN, TB , DM )

2.      Thyroid disorder

3.      Pregnant and Lactating women

4.      Patient on 0CPs , IUCD

5.      Congenital anomalies of uterus or ovaries

6.      Patient with any pelvic pathology or malignancy

7.      PCOD

8.      Hb% less than 10 gm

 Investigation – At the time of registration.

 1.      Hb%

2.      ESR

3.      FBS

4.      LFT

5.      Thyroid profile

6.      USG – Pelvic region ( Endometrial thickness )

7.      UPT

 Assessment criteria – Assessment will be done on the basis of improvement in the sign andsymptoms

for the purpose.

Subjective criteria –

1.      Interval between two cycles

2.      Duration of bleeding

3.      Amount of blood loss

4.      Pain during menstruation – assess with the helpof VAS scale